• 
• About Us
  • Our vision
  • Key facts
  • Our vaccines
• Our Commitment
  • Our mission
  • R & D
    • - Stakes
    • - Vaccines for tomorrow
    • - New technologies
    • - Become a partner
  • The challenges of production
  • Access to vaccines
• sanofi pasteur in Canada
  • A Short History
  • Our Founder
  • Public Health Partner
• Our vaccines
  • List of vaccines
  • Vaccine schedules
• Value of Vaccines
  • Vaccines save lives
  • Vaccines save money
• Media
  • Press releases
    • - Archives 2009
    • - 2007 Archives
  • Making a différence in our Community
  • Contact - Media Relations
  • Commitment to Health, Safety and Environment
  • Top Executives
  • Notice of Application for Electricity Generating Licence
• Careers
  • Working at Sanofi Pasteur
  • Apply

Home  >  About Us  >  Key facts

Sanofi Pasteur Corporate
Video Clip 

Download video transcript

Sanofi Pasteur: key facts

A global company:

• Headquarters: Lyon, France
• Revenue: €3,483 million in 2009 (+19.2% compared to 2008 at constant exchange rates) 
• More than 12,500 employees worldwide
• More than 50% of staff devoted to industrial operations
• 11 production and/or R&D sites located in Marcy l'Etoile and Val de Reuil, France; in Swiftwater (Pennsylvania), Cambridge and Canton (Massachusetts), and Rockville (Maryland), USA; in Toronto, Canada; in Pilar, Argentina; in Shenzhen, China; in Hyderabad, India and in Chachoengsao, Thailand. 
• 3 new facilities under construction in Ocoyoacac, Mexico ; Neuville, France ; and Shenzhen, China.

Investment in research and production capacity:

• More than 1.6 billion doses of vaccines produced yearly to immunize more than 500 million people in the world
• Largest product range available, against 20 infectious diseases
• More than €1 million invested every day in R&D
• More than €1.6 billion invested in the last 5 years in production infrastructures.